Skip to main content

Table 2 Treatment outcomes

From: Efficacy and safety of edoxaban tosylate hydrate 15 mg in the prevention of venous thromboembolism in patients with impaired renal function after orthopedic surgery of the lower extremities

 

Edoxaban 15 mg (n = 23)

Edoxaban 30 mg (n = 209)

p value

OR (95% CI)

Proximal DVT

0

0

1.00

0

Distal DVT

2 (8.7%)

18 (8.6%)

1.00

0.99(0.22–4.56)

PTE

0

0

1.00

0

  1. CI, confidence interval; DVT, deep venous thrombosis; OR, odds ratio; PTE, pulmonary thromboembolism
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us